Hepatic Fibrosis Biomarkers Market By Diagnostic Technique (Imaging Techniques {Magnetic Resonance Elastography, Ultrasound-based Elastography, CT-based Techniques}, Serum-based Tests {Direct Biomarkers, Indirect Biomarkers}, Molecular Diagnostics), By Application (Diagnostic Testing, Prognostic Testing, Drug Discovery & Development, Clinical Trials Monitoring, Personalized Medicine), By Biomarker Type (Serum Biomarkers, Imaging Biomarkers, Genetic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers), By Biomarker Origin (Extracellular Matrix Biomarkers, Inflammatory Biomarkers, Genetic & Epigenetic Biomarkers), and By End User (Hospitals & Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical & Biotechnology Companies, Academic Centers), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & Forecast Parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Hepatic Fibrosis Biomarkers Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. How does increasing prevalence of liver diseases influence biomarker development?

3.2.2. Can rising demand for non-invasive diagnostics drive biomarker innovation?

3.2.3. Is growing research funding accelerating advancements in fibrosis biomarker technologies?

3.3. Key industry pitfalls & challenges

3.3.1. Do high diagnostic costs limit accessibility for widespread patient use?

3.3.2. Is lack of standardization across biomarker tests slowing clinical adoption?

3.3.3. Can insufficient awareness among physicians hinder biomarker-based decision-making?

3.4. Market Opportunities

3.4.1. Will artificial intelligence enhance accuracy of biomarker-based fibrosis detection?

3.4.2. Can emerging markets increase demand for affordable diagnostic biomarker kits?

3.4.3. Is personalized medicine creating need for novel hepatic biomarker solutions?

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Hepatic Fibrosis Biomarkers Market, Diagnostic Technique Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Diagnostic Technique, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Imaging Techniques

4.2.1. Market Size and Forecast, 2025-2035 (USD Million)

4.2.2. Magnetic Resonance Elastography

4.2.2.1. Market Size and Forecast, 2025-2035 (USD Million)

4.2.3. Ultrasound-based Elastography

4.2.3.1. Market Size and Forecast, 2025-2035 (USD Million)

4.2.4. CT-based Techniques

4.2.4.1. Market Size and Forecast, 2025-2035 (USD Million)

4.3. Serum-based Tests

4.3.1. Market Size and Forecast, 2025-2035 (USD Million)

4.3.2. Direct Biomarkers

4.3.2.1. Market Size and Forecast, 2025-2035 (USD Million)

4.3.3. Indirect Biomarkers

4.3.3.1. Market Size and Forecast, 2025-2035 (USD Million)

4.4. Molecular Diagnostics

4.4.1. Market Size and Forecast, 2025-2035 (USD Million)

5. Hepatic Fibrosis Biomarkers Market, Application Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Application, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Diagnostic Testing

5.2.1. Market Size and Forecast, 2025-2035 (USD Million)

5.3. Prognostic Testing

5.3.1. Market Size and Forecast, 2025-2035 (USD Million)

5.4. Drug Discovery & Development

5.4.1. Market Size and Forecast, 2025-2035 (USD Million)

5.5. Clinical Trials Monitoring

5.5.1. Market Size and Forecast, 2025-2035 (USD Million)

5.6. Personalized Medicine

5.6.1. Market Size and Forecast, 2025-2035 (USD Million)

6. Hepatic Fibrosis Biomarkers Market, Biomarker Type Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Biomarker Type, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Serum Biomarkers

6.2.1. Market Size and Forecast, 2025-2035 (USD Million)

6.3. Imaging Biomarkers

6.3.1. Market Size and Forecast, 2025-2035 (USD Million)

6.4. Genetic Biomarkers

6.4.1. Market Size and Forecast, 2025-2035 (USD Million)

6.5. Proteomic Biomarkers

6.5.1. Market Size and Forecast, 2025-2035 (USD Million)

6.6. Metabolomic Biomarkers

6.6.1. Market Size and Forecast, 2025-2035 (USD Million)

7. Hepatic Fibrosis Biomarkers Market, Biomarker Origin Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Biomarker Origin, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Extracellular Matrix Biomarkers

7.2.1. Market Size and Forecast, 2025-2035 (USD Million)

7.3. Inflammatory Biomarkers

7.3.1. Market Size and Forecast, 2025-2035 (USD Million)

7.4. Genetic & Epigenetic Biomarkers

7.4.1. Market Size and Forecast, 2025-2035 (USD Million)

8. Hepatic Fibrosis Biomarkers Market, End-user Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By End-user, 2025 & 2035

8.1.2. Key Market Trends, Growth Factors, & Opportunities

8.2. Hospitals & Clinics

8.2.1. Market Size and Forecast, 2025-2035 (USD Million)

8.3. Diagnostic Laboratories

8.3.1. Market Size and Forecast, 2025-2035 (USD Million)

8.4. Research Institutes

8.4.1. Market Size and Forecast, 2025-2035 (USD Million)

8.5. Pharmaceutical & Biotechnology Companies

8.5.1. Market Size and Forecast, 2025-2035 (USD Million)

8.6. Academic Centers

8.6.1. Market Size and Forecast, 2025-2035 (USD Million)

9. Hepatic Fibrosis Biomarkers Market, Region Segment Analysis

9.1. Overview

9.1.1. Global Market Revenue Share, By Region, 2025 & 2035

9.1.2. Global Market Revenue, By Region, 2025-2035 (USD Million)

9.2. North America

9.2.1. North America Market Revenue, By Country, 2025-2035 (USD Million)

9.2.2. North America Market Revenue, By Diagnostic Technique, 2025-2035

9.2.3. North America Market Revenue, By Application, 2025-2035

9.2.4. North America Market Revenue, By Biomarker Type, 2025-2035

9.2.5. North America Market Revenue, By Biomarker Origin, 2025-2035

9.2.6. North America Market Revenue, By End-user, 2025-2035

9.2.7. The U.S.

9.2.7.1. U.S. Market Revenue, By Diagnostic Technique, 2025-2035

9.2.7.2. U.S. Market Revenue, By Application, 2025-2035

9.2.7.3. U.S. Market Revenue, By Biomarker Type, 2025-2035

9.2.7.4. U.S. Market Revenue, By Biomarker Origin, 2025-2035

9.2.7.5. U.S. Market Revenue, By End-user, 2025-2035

9.2.8. Canada

9.2.8.1. Canada Market Revenue, By Diagnostic Technique, 2025-2035

9.2.8.2. Canada Market Revenue, By Application, 2025-2035

9.2.8.3. Canada Market Revenue, By Biomarker Type, 2025-2035

9.2.8.4. Canada Market Revenue, By Biomarker Origin, 2025-2035

9.2.8.5. Canada Market Revenue, By End-user, 2025-2035

9.3. Europe

9.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Million)

9.3.2. Europe Market Revenue, By Diagnostic Technique, 2025-2035

9.3.3. Europe Market Revenue, By Application, 2025-2035

9.3.4. Europe Market Revenue, By Biomarker Type, 2025-2035

9.3.5. Europe Market Revenue, By Biomarker Origin, 2025-2035

9.3.6. Europe Market Revenue, By End-user, 2025-2035

9.3.7. Germany

9.3.7.1. Germany Market Revenue, By Diagnostic Technique, 2025-2035

9.3.7.2. Germany Market Revenue, By Application, 2025-2035

9.3.7.3. Germany Market Revenue, By Biomarker Type, 2025-2035

9.3.7.4. Germany Market Revenue, By Biomarker Origin, 2025-2035

9.3.7.5. Germany Market Revenue, By End-user, 2025-2035

9.3.8. France

9.3.8.1. France Market Revenue, By Diagnostic Technique, 2025-2035

9.3.8.2. France Market Revenue, By Application, 2025-2035

9.3.8.3. France Market Revenue, By Biomarker Type, 2025-2035

9.3.8.4. France Market Revenue, By Biomarker Origin, 2025-2035

9.3.8.5. France Market Revenue, By End-user, 2025-2035

9.3.9. U.K.

9.3.9.1. U.K. Market Revenue, By Diagnostic Technique, 2025-2035

9.3.9.2. U.K. Market Revenue, By Application, 2025-2035

9.3.9.3. U.K. Market Revenue, By Biomarker Type, 2025-2035

9.3.9.4. U.K. Market Revenue, By Biomarker Origin, 2025-2035

9.3.9.5. U.K. Market Revenue, By End-user, 2025-2035

9.3.10. Italy

9.3.10.1. Italy Market Revenue, By Diagnostic Technique, 2025-2035

9.3.10.2. Italy Market Revenue, By Application, 2025-2035

9.3.10.3. Italy Market Revenue, By Biomarker Type, 2025-2035

9.3.10.4. Italy Market Revenue, By Biomarker Origin, 2025-2035

9.3.10.5. Italy Market Revenue, By End-user, 2025-2035

9.3.11. Spain

9.3.11.1. Spain Market Revenue, By Diagnostic Technique, 2025-2035

9.3.11.2. Spain Market Revenue, By Application, 2025-2035

9.3.11.3. Spain Market Revenue, By Biomarker Type, 2025-2035

9.3.11.4. Spain Market Revenue, By Biomarker Origin, 2025-2035

9.3.11.5. Spain Market Revenue, By End-user, 2025-2035

9.3.12. Rest of Europe

9.3.12.1. Rest of Europe Market Revenue, By Diagnostic Technique, 2025-2035

9.3.12.2. Rest of Europe Market Revenue, By Application, 2025-2035

9.3.12.3. Rest of Europe Market Revenue, By Biomarker Type, 2025-2035

9.3.12.4. Rest of Europe Market Revenue, By Biomarker Origin, 2025-2035

9.3.12.5. Rest of Europe Market Revenue, By End-user, 2025-2035

9.4. Asia Pacific

9.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Million)

9.4.2. Asia Pacific Market Revenue, By Diagnostic Technique, 2025-2035

9.4.3. Asia Pacific Market Revenue, By Application, 2025-2035

9.4.4. Asia Pacific Market Revenue, By Biomarker Type, 2025-2035

9.4.5. Asia Pacific Market Revenue, By Biomarker Origin, 2025-2035

9.4.6. Asia Pacific Market Revenue, By End-user, 2025-2035

9.4.7. China

9.4.7.1. China Market Revenue, By Diagnostic Technique, 2025-2035

9.4.7.2. China Market Revenue, By Application, 2025-2035

9.4.7.3. China Market Revenue, By Biomarker Type, 2025-2035

9.4.7.4. China Market Revenue, By Biomarker Origin, 2025-2035

9.4.7.5. China Market Revenue, By End-user, 2025-2035

9.4.8. Japan

9.4.8.1. Japan Market Revenue, By Diagnostic Technique, 2025-2035

9.4.8.2. Japan Market Revenue, By Application, 2025-2035

9.4.8.3. Japan Market Revenue, By Biomarker Type, 2025-2035

9.4.8.4. Japan Market Revenue, By Biomarker Origin, 2025-2035

9.4.8.5. Japan Market Revenue, By End-user, 2025-2035

9.4.9. India

9.4.9.1. India Market Revenue, By Diagnostic Technique, 2025-2035

9.4.9.2. India Market Revenue, By Application, 2025-2035

9.4.9.3. India Market Revenue, By Biomarker Type, 2025-2035

9.4.9.4. India Market Revenue, By Biomarker Origin, 2025-2035

9.4.9.5. India Market Revenue, By End-user, 2025-2035

9.4.10. Australia

9.4.10.1. Australia Market Revenue, By Diagnostic Technique, 2025-2035

9.4.10.2. Australia Market Revenue, By Application, 2025-2035

9.4.10.3. Australia Market Revenue, By Biomarker Type, 2025-2035

9.4.10.4. Australia Market Revenue, By Biomarker Origin, 2025-2035

9.4.10.5. Australia Market Revenue, By End-user, 2025-2035

9.4.11. South Korea

9.4.11.1. South Korea Market Revenue, By Diagnostic Technique, 2025-2035

9.4.11.2. South Korea Market Revenue, By Application, 2025-2035

9.4.11.3. South Korea Market Revenue, By Biomarker Type, 2025-2035

9.4.11.4. South Korea Market Revenue, By Biomarker Origin, 2025-2035

9.4.11.5. South Korea Market Revenue, By End-user, 2025-2035

9.4.12. Singapore

9.4.12.1. Singapore Market Revenue, By Diagnostic Technique, 2025-2035

9.4.12.2. Singapore Market Revenue, By Application, 2025-2035

9.4.12.3. Singapore Market Revenue, By Biomarker Type, 2025-2035

9.4.12.4. Singapore Market Revenue, By Biomarker Origin, 2025-2035

9.4.12.5. Singapore Market Revenue, By End-user, 2025-2035

9.4.13. Rest of Asia Pacific

9.4.13.1. Rest of Asia Pacific Market Revenue, By Diagnostic Technique, 2025-2035

9.4.13.2. Rest of Asia Pacific Market Revenue, By Application, 2025-2035

9.4.13.3. Rest of Asia Pacific Market Revenue, By Biomarker Type, 2025-2035

9.4.13.4. Rest of Asia Pacific Market Revenue, By Biomarker Origin, 2025-2035

9.4.13.5. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

9.5. Latin America

9.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Million)

9.5.2. Latin America Market Revenue, By Diagnostic Technique, 2025-2035

9.5.3. Latin America Market Revenue, By Application, 2025-2035

9.5.4. Latin America Market Revenue, By Biomarker Type, 2025-2035

9.5.5. Latin America Market Revenue, By Biomarker Origin, 2025-2035

9.5.6. Latin America Market Revenue, By End-user, 2025-2035

9.5.7. Brazil

9.5.7.1. Brazil Market Revenue, By Diagnostic Technique, 2025-2035

9.5.7.2. Brazil Market Revenue, By Application, 2025-2035

9.5.7.3. Brazil Market Revenue, By Biomarker Type, 2025-2035

9.5.7.4. Brazil Market Revenue, By Biomarker Origin, 2025-2035

9.5.7.5. Brazil Market Revenue, By End-user, 2025-2035

9.5.8. Argentina

9.5.8.1. Argentina Market Revenue, By Diagnostic Technique, 2025-2035

9.5.8.2. Argentina Market Revenue, By Application, 2025-2035

9.5.8.3. Argentina Market Revenue, By Biomarker Type, 2025-2035

9.5.8.4. Argentina Market Revenue, By Biomarker Origin, 2025-2035

9.5.8.5. Argentina Market Revenue, By End-user, 2025-2035

9.5.9. Mexico

9.5.9.1. Mexico Market Revenue, By Diagnostic Technique, 2025-2035

9.5.9.2. Mexico Market Revenue, By Application, 2025-2035

9.5.9.3. Mexico Market Revenue, By Biomarker Type, 2025-2035

9.5.9.4. Mexico Market Revenue, By Biomarker Origin, 2025-2035

9.5.9.5. Mexico Market Revenue, By End-user, 2025-2035

9.5.10. Rest of Latin America

9.5.10.1. Rest of Latin America Market Revenue, By Diagnostic Technique, 2025-2035

9.5.10.2. Rest of Latin America Revenue, By Application, 2025-2035

9.5.10.3. Rest of Latin America Market Revenue, By Biomarker Type, 2025-2035

9.5.10.4. Rest of Latin America Market Revenue, By Biomarker Origin, 2025-2035

9.5.10.5. Rest of Latin America Market Revenue, By End-user, 2025-2035

9.6. MEA

9.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Million)

9.6.2. MEA Market Revenue, By Diagnostic Technique, 2025-2035

9.6.3. MEA Market Revenue, By Application, 2025-2035

9.6.4. MEA Market Revenue, By Biomarker Type, 2025-2035

9.6.5. MEA Market Revenue, By Biomarker Origin, 2025-2035

9.6.6. MEA Market Revenue, By End-user, 2025-2035

9.6.7. GCC Countries

9.6.7.1. GCC Countries Market Revenue, By Diagnostic Technique, 2025-2035

9.6.7.2. GCC Countries Market Revenue, By Application, 2025-2035

9.6.7.3. GCC Countries Market Revenue, By Biomarker Type, 2025-2035

9.6.7.4. GCC Countries Market Revenue, By Biomarker Origin, 2025-2035

9.6.7.5. GCC Countries Market Revenue, By End-user, 2025-2035

9.6.8. South Africa

9.6.8.1. South Africa Market Revenue, By Diagnostic Technique, 2025-2035

9.6.8.2. South Africa Market Revenue, By Application, 2025-2035

9.6.8.3. South Africa Market Revenue, By Biomarker Type, 2025-2035

9.6.8.4. South Africa Market Revenue, By Biomarker Origin, 2025-2035

9.6.8.5. South Africa Market Revenue, By End-user, 2025-2035

9.6.9. Rest of Middle-East & Africa

9.6.9.1. Rest of Middle-East & Africa Market Revenue, By Diagnostic Technique, 2025-2035

9.6.9.2. Rest of Middle-East & Africa Market Revenue, By Application, 2025-2035

9.6.9.3. Rest of Middle-East & Africa Market Revenue, By Biomarker Type, 2025-2035

9.6.9.4. Rest of Middle-East & Africa Market Revenue, By Biomarker Origin, 2025-2035

9.6.9.5. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

10. Company Profile

10.1. Genfit SA

10.1.1. Business Overview

10.1.2. Financial Performance

10.1.3. Product/Service Offerings

10.1.4. Strategies & recent developments

10.1.5. SWOT Analysis

10.2. BioPredictive S.A.S.

10.2.1. Business Overview

10.2.2. Financial Performance

10.2.3. Product/Service Offerings

10.2.4. Strategies & recent developments

10.2.5. SWOT Analysis

10.3. Nordic Bioscience

10.3.1. Business Overview

10.3.2. Financial Performance

10.3.3. Product/Service Offerings

10.3.4. Strategies & recent developments

10.3.5. SWOT Analysis

10.4. Siemens Healthineers AG

10.4.1. Business Overview

10.4.2. Financial Performance

10.4.3. Product/Service Offerings

10.4.4. Strategies & recent developments

10.4.5. SWOT Analysis

10.5. Labcorp

10.5.1. Business Overview

10.5.2. Financial Performance

10.5.3. Product/Service Offerings

10.5.4. Strategies & recent developments

10.5.5. SWOT Analysis

10.6. Quest Diagnostics Incorporated

10.6.1. Business Overview

10.6.2. Financial Performance

10.6.3. Product/Service Offerings

10.6.4. Strategies & recent developments

10.6.5. SWOT Analysis

10.7. Prometheus Laboratories Inc.

10.7.1. Business Overview

10.7.2. Financial Performance

10.7.3. Product/Service Offerings

10.7.4. Strategies & recent developments

10.7.5. SWOT Analysis

10.8. AstraZeneca plc

10.8.1. Business Overview

10.8.2. Financial Performance

10.8.3. Product/Service Offerings

10.8.4. Strategies & recent developments

10.8.5. SWOT Analysis

10.9. Bristol‑Myers Squibb Company

10.9.1. Business Overview

10.9.2. Financial Performance

10.9.3. Product/Service Offerings

10.9.4. Strategies & recent developments

10.9.5. SWOT Analysis

10.10. Pfizer Inc.

10.10.1. Business Overview

10.10.2. Financial Performance

10.10.3. Product/Service Offerings

10.10.4. Strategies & recent developments

10.10.5. SWOT Analysis

10.11. Novartis AG

10.11.1. Business Overview

10.11.2. Financial Performance

10.11.3. Product/Service Offerings

10.11.4. Strategies & recent developments

10.11.5. SWOT Analysis

10.12. Gilead Sciences, Inc.

10.12.1. Business Overview

10.12.2. Financial Performance

10.12.3. Product/Service Offerings

10.12.4. Strategies & recent developments

10.12.5. SWOT Analysis

10.13. Meridian Bioscience

10.13.1. Business Overview

10.13.2. Financial Performance

10.13.3. Product/Service Offerings

10.13.4. Strategies & recent developments

10.13.5. SWOT Analysis

10.14. NGM Biopharmaceuticals, Inc.

10.14.1. Business Overview

10.14.2. Financial Performance

10.14.3. Product/Service Offerings

10.14.4. Strategies & recent developments

10.14.5. SWOT Analysis

10.15. Perspectum Diagnostics Ltd.

10.15.1. Business Overview

10.15.2. Financial Performance

10.15.3. Product/Service Offerings

10.15.4. Strategies & recent developments

10.15.5. SWOT Analysis